NSRX Nasus Pharma Ltd.

$3.53

Nasus Pharma Ltd. (NSRX) is confirmed to report earnings on August 17, 2026, before the market open. The consensus earnings estimate is a loss of $0.18 per share.

Earnings Date
2nd Quarter, Jun 2026
Aug 17
Monday · Before Open
Earnings Whisper
-
vs ($0.18)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Nasus Pharma Ltd.

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.